5 insiders reported 7 Form 4 transactions for Lexaria Bioscience Corp. (LEXX) over the past 18 months (most recent 2026-03-18). Recent activity: BUNKA CHRISTOPHER (Director) Sell 100,000 shares, BUNKA CHRISTOPHER (Director) Buy 15,600 shares, BUNKA CHRISTOPHER (Director) Buy 11,900 shares, McKechnie William Edward (Director) Buy 5,000 shares, CHRISTOPHER RICHARD (Chief Executive Officer) Buy 15,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-18 | BUNKA CHRISTOPHER | Director | Sell | 100,000 | $0 |
| 2025-07-30 | BUNKA CHRISTOPHER | Director | Buy | 15,600 | $14,352 |
| 2025-07-30 | BUNKA CHRISTOPHER | Director | Buy | 11,900 | $10,829 |
| 2025-07-30 | McKechnie William Edward | Director | Buy | 5,000 | $4,550 |
| 2025-07-30 | CHRISTOPHER RICHARD | Chief Executive Officer | Buy | 15,000 | $13,650 |
| 2025-07-30 | Carle Vanessa | Secretary | Buy | 750 | $682 |
| 2025-07-30 | DOCHERTY JOHN MARTIN | President & CSO | Buy | 5,376 | $5,000 |
Source: SEC Form 4 filings · as of 2026-03-18